Effects of norepinephrine on oxygen consumption of quiescent and activated human peripheral blood mononuclear cells.
Lunemann
Jan D
JD
Department of Neurology, Division of Neuroimmunology, Charité University Hospital, Berlin, Germany.
Buttgereit
Frank
F
Tripmacher
Robert
R
Baerwald
Christoph G O
CG
Burmester
Gerd-Rudiger
GR
Krause
Andreas
A
D000255:Adenosine Triphosphate / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D003208:Concanavalin A / Q000494:pharmacology; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D003208:Concanavalin A; D000255:Adenosine Triphosphate; D011433:Propranolol; D009638:Norepinephrine; D010646:Phentolamine